Metonitazene-d3 Citrate – Crystalline Solid – 1 mg, 5mg

Metonitazene-d3 Citrate – Crystalline Solid – 1 mg, 5mg

Metonitazene-d3 (citrate) is an analytical reference standard intended for use as an internal standard for the quantification of metonitazene by GC- or LC-MS. Metonitazene is categorized as an opioid.1 Metonitazene has analgesic effects in mice.2 Metonitazene-d3 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

Formal Name: N,N-diethyl-2-[(4-(methoxy-d3)phenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine, 2-hydroxy-1,2,3-propanetricarboxylate
Molecular Formula: C21H23D3N4O3 • C6H8O7
Formula Weight: 577.6
Purity: ≥99% deuterated forms (d1-d3)
Formulation: A crystalline solid
Solubility
DMF: 10 mg/ml
DMSO: 10 mg/ml
PBS (pH 7.2): 1 mg/ml
λmax: 240 nm
SMILES: CCN(CC)CCN1C(CC2=CC=C(OC([2H])([2H])[2H])C=C2)=NC3=CC([N+]([O-])=O)=CC=C31.OC(CC(O)=O)(C(O)=O)CC(O)=O
InChi Code: InChI=1S/C21H26N4O3.C6H8O7/c1-4-23(5-2)12-13-24-20-11-8-17(25(26)27)15-19(20)22-21(24)14-16-6-9-18(28-3)10-7-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h6-11,15H,4-5,12-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/i3D3;
InChi Key: HJRWCNRBAWVTKS-FJCVKDQNSA-N

Regulatory Information

DEA Schedule: I

Shipping & Storage Information

Storage: -20°C
Shipping: Room temperature in continental US; may vary elsewhere
Stability: ≥ 5 years